Two popular slimming drugs have been taken off the market worldwide following
new evidence that they can cause heart problems. In one study, 30 per cent of
people taking fenfluramine or dexfenluramine, also known as Redux, showed signs
of abnormal heart valve function. Neuroscientists have also expressed concern
that the drugs could damage the brain
(This Week, 28 June, p 10).
More from New Scientist
Explore the latest news, articles and features
Technology
US government wants to have a useful quantum computer by 2028
News
Life
Childbirth for many primate species is even harder than for humans
News
Humans
Humans sleep the least of all apes – is it the secret to our success?
Features
91É«ÇéƬ
Your menstrual cycle may affect how well vaccines work
News
Popular articles
Trending New Scientist articles
1
Where, when and how to watch the 2026 solar eclipse
2
Humans sleep the least of all apes – is it the secret to our success?
3
Remote-controlled cockroach swarm can now breathe underwater
4
If you aren't terrified by this heatwave, you should be
5
The best sci-fi novel in 2026 so far – plus 6 other great reads
6
Our verdict on The Selfish Gene: An unpopular piece of popular science
7
US government wants to have a useful quantum computer by 2028
8
We’ve uncovered a master gene that switches on human development
9
Lost books by ancient philosophers recovered from 'unreadable' scrolls
10
Europe’s heatwave is the hottest and most humid ever
